Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Animal studies published in Neuropharmacology (2023) showed KLOW reduced astrocyte reactivity and oxidative stress markers in induced neuroinflammation by approximately 40% versus saline controls
Pal-GHK is a synthetic hybrid peptide with one fatty acid and one peptide
doi: 10.1126/science.aba3683 55 DannenbergLZikeliDBenkhoffMAhlbrechtSKelmMLevkauBet al
Contraindications include: Active cancer or history of certain cancers (due to growth factor effects) Pregnancy or breastfeeding Known copper metabolism disorders Active infections at injection sites Always work with a knowledgeable physician who understands peptide therapy and can monitor your response appropriately
US$ 25.71
US$ 25.30
US$ 21.40
US$ 29.52
US$ 23.06
